Review decisions
Showing 480 results of 688 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00395
… receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy. In … HR-positive, HER2-negative advanced or metastatic breast cancer, as initial endocrine-based therapy or following … receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy; In …
Product Type: Drug
Control Number: 203884
DIN(s): 02473569
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2017-03-17
Issued / Original Publication Date: 2018-06-18
Decision / Authorization Date: 2018-03-02
Updated Date: 2024-12-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00232
… locally advanced or metastatic squamous non-small cell lung cancer. Patients with locally advanced disease should be … growth inhibition in the setting of non-small cell lung cancer (adenocarcinoma and squamous carcinoma types of the lung), colorectal cancer, and other types of tumors. The pivotal 2-arm, phase …
Product Type: Drug
Control Number: 193689
Manufacturer: Eli Lilly Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2016-03-22
Decision / Authorization Date: 2017-03-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00152
… is authorized for sale in Canada to treat 2 types of blood cancer: relapsed chronic lymphocytic leukemia, and … authorized for sale in Canada to treat 2 types of blood cancers: relapsed chronic lymphocytic leukemia and … antineoplastic agents that acts by changing the growth of cancerous white blood cells, causing them to die. The drug …
Issued / Original Publication Date: 2017-03-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00150
… stents and bevacizumab are used together to treat colon cancer patients Key Messages Colorectal stents are medical … for sale in Canada as part of the treatment of certain cancers including those in the bowel. Health Canada reviewed … stents and bevacizumab are used together to treat colon cancer patients. Health Canada will issue a Health Product …
Issued / Original Publication Date: 2017-02-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00148
… too large and weak (Paget's disease of bone); the spread of cancer to bone (bone metastases); an increase in calcium levels in the blood due to cancer (hypercalcemia of malignancy); and a particular type of blood cell cancer known as multiple myeloma. Bisphosphonates have been …
Issued / Original Publication Date: 2017-02-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00344
… 20 (71%) underwent liver transplantation, for cirrhosis or cancer (13 patients), acute hepatic failure (2) or …
Product Type: Drug
Control Number: 193226
DIN(s): 02459698, 02459701, 02459728, 02459736, 02469693
Manufacturer: Swedish Orphan Biovitrum Ab (publ)
Submission Type: New Drug Submission
Issued / Original Publication Date: 2017-02-17
Updated Date: 2019-04-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00384
… Stage II, IIIA, or IIIB (T3-4 N2) non-small cell lung cancer (NSCLC) and no known epidermal growth factor receptor … of patients with resectable muscle invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin … of adult patients with metastatic non-small cell lung cancer (NSCLC) with no sensitizing epidermal growth factor …
Product Type: Drug
Control Number: 202953
DIN(s): 02468816
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2017-02-16
Issued / Original Publication Date: 2018-02-22
Decision / Authorization Date: 2017-11-03
Updated Date: 2026-04-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00342
Product Type: Drug
Control Number: 190458
DIN(s): 02459620
Manufacturer: Biogen Canada Inc.
Submission Type: New Drug Submission
Issued / Original Publication Date: 2017-02-09
Updated Date: 2018-12-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00388
… there did not appear to be an increased risk for individual cancer types, including thyroid neoplasms. However, the …
Product Type: Drug
Control Number: 202059
DIN(s): 02471469, 02471477, 02523930, 02540258
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2017-01-19
Issued / Original Publication Date: 2018-04-04
Decision / Authorization Date: 2018-01-04
Updated Date: 2025-07-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00143
… psoriasis. Tretinoin is also used to treat a type of blood cancer. Health Canada reviewed the potential risk of … is also authorized for sale in Canada to treat a type of cancer of the blood (acute promyelocytic leukemia). At the …
Issued / Original Publication Date: 2017-01-10